Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the phase II defactinib and VS-6766 trial in metastatic uveal melanoma, with study details, outcome measures, and supporting documentation.
    Difference
    64%
    Check dated 2026-11-07T14:27:51.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:14:44.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T16:20:53.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:13:29.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:15:18.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record and navigation, with the original study content no longer visible. This change represents an access restriction rather than a new or updated content item.
    Difference
    21%
    Check dated 2026-09-19T20:44:37.000Z thumbnail image

Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.